abstract |
The present invention relates to an anti-tumor composition comprising tumor cell lysates subjected to photodynamic treatment and an immunoadjuvant selected from CpG-ODN, interferon, interleukin or cyclosporin A. The anti-tumor composition of the present invention is superior to the anti-tumor effect compared with the case of using a photodynamic treatment tumor cell lysate or an adjuvant, respectively, can increase the expression of various immune-related substances, can be used more stably in the individual. |